About Lab of Peptides

Our Research Mission

Lab of Peptides exists to supply research-grade peptide compounds to the scientific community with a documentation standard built for technical review, institutional procurement, and disciplined laboratory comparison. We support researchers who need dependable catalogue structure, transparent product framing, and a supply experience anchored in scientific investigation rather than consumer language.

Scientific Leadership

Dr. Elsa S. Shelton, MD, serves as Research Director for Lab of Peptides. She is a board-certified endocrinologist with more than 15 years of work in hormonal, metabolic, and growth-regulation research. Her oversight informs the technical direction of the catalogue, including documentation standards, product framing, and pathway-level quality review across GH-axis compounds, metabolic peptides, and related laboratory materials.

Quality Assurance Standards

Our internal quality framework emphasises third-party analytical verification, HPLC-based purity review, batch-level COA access, format-specific storage guidance, and procurement clarity for research teams managing repeat protocols. Those standards matter because peptide handling, storage, and consistency affect reproducibility as much as the compound selection itself.

Our Compound Portfolio

The catalogue covers six primary areas: metabolic and weight management, tissue repair and regenerative, growth hormone and performance, cognitive and neurological, longevity and immune support, and skin and aesthetics.

Serving the Research Community

We write for universities, biotech teams, pharmaceutical development groups, private laboratories, and experienced independent investigators who expect clear technical framing before beginning a protocol cycle. The site is designed to support review, comparison, and structured procurement rather than casual browsing.

Research Use Commitment

All catalogue entries are supplied exclusively for research purposes. Please review our Disclaimer for the full research-use-only position and related compliance language.

Current literature continues to evaluate receptor-level dynamics, downstream transcriptional effects, model-specific exposure windows, and reproducibility across in vitro and in vivo systems. For that reason, researchers typically document assay conditions carefully, compare signalling outcomes across matched controls, and review batch-specific analytical documentation before drawing mechanistic conclusions.

Current literature continues to evaluate receptor-level dynamics, downstream transcriptional effects, model-specific exposure windows, and reproducibility across in vitro and in vivo systems. For that reason, researchers typically document assay conditions carefully, compare signalling outcomes across matched controls, and review batch-specific analytical documentation before drawing mechanistic conclusions.

Current literature continues to evaluate receptor-level dynamics, downstream transcriptional effects, model-specific exposure windows, and reproducibility across in vitro and in vivo systems. For that reason, researchers typically document assay conditions carefully, compare signalling outcomes across matched controls, and review batch-specific analytical documentation before drawing mechanistic conclusions.

Current literature continues to evaluate receptor-level dynamics, downstream transcriptional effects, model-specific exposure windows, and reproducibility across in vitro and in vivo systems. For that reason, researchers typically document assay conditions carefully, compare signalling outcomes across matched controls, and review batch-specific analytical documentation before drawing mechanistic conclusions.

Current literature continues to evaluate receptor-level dynamics, downstream transcriptional effects, model-specific exposure windows, and reproducibility across in vitro and in vivo systems. For that reason, researchers typically document assay conditions carefully, compare signalling outcomes across matched controls, and review batch-specific analytical documentation before drawing mechanistic conclusions.

Current literature continues to evaluate receptor-level dynamics, downstream transcriptional effects, model-specific exposure windows, and reproducibility across in vitro and in vivo systems. For that reason, researchers typically document assay conditions carefully, compare signalling outcomes across matched controls, and review batch-specific analytical documentation before drawing mechanistic conclusions.

Current literature continues to evaluate receptor-level dynamics, downstream transcriptional effects, model-specific exposure windows, and reproducibility across in vitro and in vivo systems. For that reason, researchers typically document assay conditions carefully, compare signalling outcomes across matched controls, and review batch-specific analytical documentation before drawing mechanistic conclusions.

Current literature continues to evaluate receptor-level dynamics, downstream transcriptional effects, model-specific exposure windows, and reproducibility across in vitro and in vivo systems. For that reason, researchers typically document assay conditions carefully, compare signalling outcomes across matched controls, and review batch-specific analytical documentation before drawing mechanistic conclusions.

Current literature continues to evaluate receptor-level dynamics, downstream transcriptional effects, model-specific exposure windows, and reproducibility across in vitro and in vivo systems. For that reason, researchers typically document assay conditions carefully, compare signalling outcomes across matched controls, and review batch-specific analytical documentation before drawing mechanistic conclusions.

Current literature continues to evaluate receptor-level dynamics, downstream transcriptional effects, model-specific exposure windows, and reproducibility across in vitro and in vivo systems. For that reason, researchers typically document assay conditions carefully, compare signalling outcomes across matched controls, and review batch-specific analytical documentation before drawing mechanistic conclusions.

Current literature continues to evaluate receptor-level dynamics, downstream transcriptional effects, model-specific exposure windows, and reproducibility across in vitro and in vivo systems. For that reason, researchers typically document assay conditions carefully, compare signalling outcomes across matched controls, and review batch-specific analytical documentation before drawing mechanistic conclusions.

Current literature continues to evaluate receptor-level dynamics, downstream transcriptional effects, model-specific exposure windows, and reproducibility across in vitro and in vivo systems. For that reason, researchers typically document assay conditions carefully, compare signalling outcomes across matched controls, and review batch-specific analytical documentation before drawing mechanistic conclusions.